Skip to Content

Label Changes for:

Reglan (metoclopramide) tablets

September 2009

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2009


The goal of this REMS is to minimize the risk of tardive dyskinesia associated with the longterm use of Reglan tablets.


A Medication Guide will be dispensed with each Reglan tablet prescription.